• 한국직업건강간호학회지
• /
• 제4권호
• /
• pp.84-101
• /
• 1995

The periodic health examination have been shown the important role on early detection, early treatment and prevention of disease. Until now, there have been many studies that showed the effectiveness of the periodic health examination on the early detection and early treatment of disease to some extent. But there are few studies about primary prevention before health problem arise. In this case-control study, 29 newly detected hypertensive cases, 31 liver disease cases and 65 controls which are all available for 6-year data in the periodic health examination of a occupational field were compared to investigate the significant increase trend of health status between the groups. The results will be used for the occupational health nurses to provide appropriate primary prevention to the employees. The hypertensive and liver disease cases were divided observation-needed group and treatment-needed group. The data on systolic blood pressure, diastolic blood pressure, Body Mass Index and Broca Index in hypertensive cases and SGOT, SGPT, Body Mass Index and Broca Index in liver disease cases were analyzed by t-test and ANOVA. The specific findings are summarized as follows. 1. In the comparison between the hypertensive cases and controls, SBP and DBP of the observation-needed group and the treatment-needed group were significantly higher than the data of the controls for past 6 years. It was 2-3 years ago showing increase over 140/90mmHg of blood pressure in the hypertensive cases before they are categorized as hypertensive cases. In the observation-needed group and the treatment-needed group, the trend of the blood pressure for 6 years were significantly higher than the one of the controls. 2. In the comparison between the liver disease cases and controls, SGOT and SGPT of the observation-needed group and the treatment-needed group were significantly higher than the data of the controls for past 6 years. It was 2 years ago showing increase within upper normal limit of SGOT and 5 years ago of SGPT in the liver disease cases before they are categorized as liver disease cases. In the observation-needed group and the treatment-needed group, the trend of the liver enzyme for 6 years were significantly higher than the one of the controls. With these results, the author proposed that intervention for the primary prevention such as continuous follow-up, health education and weight control to the population who has over 140/90mmHg of blood pressure and upper normal limit of AST and ALT.

• 대한한방내과학회지
• /
• 제41권6호
• /
• pp.1231-1244
• /
• 2020

Objective: This study was conducted to report the glucose-lowering effect and safety of herbal extracts in patients with type 2 diabetes mellitus. Methods: We investigated 21 patients with type 2 diabetes mellitus who were administered Daeshiho-tang, Bojungikgi-tang, Jowiseunggi-tang, and Hoechunyanggyeok-san at Kyung-Hee University Korean Medical Hospital from 2014 to 2019. The hypoglycemic effect of the herbal extracts was assessed by comparing blood glucose levels, including fasting blood sugar (FBS) and 2-hour postprandial glucose (PP2) levels. For safety assessment, the effects of herbal extracts on liver and kidney function were analyzed by liver function tests, including aspartate aminotransferase (AST), alanine aminotransferase (ALT), and γ-glutamyltransferase (GGT), and kidney function tests, including blood urea nitrogen (BUN) and creatinine (Cr). Patients were stratified according to their glycated hemoglobin (<6.5 or >6.5) levels and the kind of herbal extract used for treatment. Results: After administration of herbal extracts, FBS and PP2 significantly decreased to 20.24 mg/dL and 35.0 mg/dL respectively. Subgroup analysis revealed that, regardless of the glycated hemoglobin level, FBS and PP2 were significantly reduced in both groups. The safety profile showed no significant difference before and after taking herbal extracts. Conclusions: Daeshigo-tang, Bojungikgi-tang, Jowiseunggi-tang, and Hoechunyanggyeok-san may show the further glucose-lowering effects on patients with type 2 diabetes mellitus who have already treated with anti-hyperglycemic agents.

• 대한한방내과학회지
• /
• 제44권4호
• /
• pp.661-674
• /
• 2023

Abstract: This retrospective study delved into the effects and safety considerations associated with the concomitant usage of hypoglycemic agents and herbal extracts, specifically Pyeongwi-san (PWS) or HyangsaPyongwi-san (HSPWS) in the context of type 2 diabetes mellitus management. Methods: The investigation involved 38 inpatients with type 2 diabetes mellitus who received PWS or HSPWS treatment at Kyung Hee University Korean Medical Hospital from January 2012 to December 2022. By investigating clinical attributes and conducting laboratory assessments, this study aimed to discern the impact of these herbal extracts on blood glucose levels, encompassing fasting blood sugar (FBS) and mean 2-hour postprandial glucose (PP2) levels. Furthermore, the safety profile of the herbal extracts was assessed by comparing liver function indicators, including aspartate aminotransferase (AST), alanine aminotransferase (ALT), and γ-glutamyl transferase (GGT), alongside kidney function markers, such as blood urea nitrogen (BUN) and creatinine (Cr). Results: Following the administration of the herbal extracts, no statistically significant alterations in FBS and mean PP2 levels emerged compared to the baseline levels. Notably, the safety evaluation revealed no significant differences in liver and kidney function parameters following herbal extract administration. Conclusion: The results of this research indicate that using PWS or HSPWS alongside hypoglycemic medications could be a beneficial additional method for addressing digestive symptoms in individuals with type 2 diabetes mellitus. Notably, this combination seems to have no negative interactions with other drugs.

• Journal of Ginseng Research
• /
• 제32권4호
• /
• pp.382-389
• /
• 2008

TCDD가 실험동물에 노출되었을 때 유발되는 생체독성을 예방 또는 억제할 수 있는 고려홍삼 추출물의 효과를 탐색하였다. 이를 위하여 TCDD($25\;{\mu}g/kg$ bw, 1회 투여)와 홍삼추출물(100 mg/kg bw, 격일투여)을 각각 단독 또는 병행 복강 투여한 다음 32일 동안에 체중과 각 장기들의 무게의 변화, 뇨 분석, 혈액학적 및 혈액화학적 변화를 관찰하였다. TCDD의 단독투여에 의하여 체중의 증가정도가 정상군 또는 홍삼단독 투여군의 체중증가율에 비하여 상당히 감소하였다. TCDD와 홍삼추출물을 병행 투여한 흰쥐에서의 체중증가율은 TCDD 단독투여에 의해 감소된 체중증가율을 다소 회복 시키는 결과를 나타내었다. TCDD를 단독 투여한 실험군에서는 간의 무게가 TCDD 투여 후 2, 5, 및 16일째에 대조군에 비하여 특이적으로 증가하는 특징을 보였으나, 홍삼추출물을 단독 투여한 실험군에서의 간의 무게는 대조군의 간의 무게에 비하여 다소 감소하였다. TCDD와 홍삼추출물이 병행 투여된 흰쥐에서의 간의 무게의 증가정도는 TCDD을 단독투여한 흰쥐 간의 무게에 비하여 약간 감소하였다. TCDD를 단독투여한 흰쥐에서의 신장(Kidney)의 무게는 대조군에 비하여 다소 감소하였으나 통계적으로는 유의하지 않았다. TCDD와 홍삼추출물을 병행투여한 흰쥐에서의 신장의 무게의 변화는 TCDD를 단독 투여한 흰쥐에서의 결과와 차이가 없었다. 홍삼추출물 단독 투여군에서의 신장의 무게는 실험초기(1-2일)에 대조군에 비하여 다소 감소하는 경향을 보였으나 5일 째부터는 대조군과 같은 수준으로 회복되었다. Spleen은 TCDD의 단독투여에 의해 2-3일 이내에 일시적인 감소가 있었으나 노출기간이 증가할수록 대조군 수준으로 회복되었다. 홍삼추출물단독 투여군과 TCDD와 홍삼추출물의 병행투여군에서 spleen의 무게는 대조군에 비하여 투여 후 16일 이후에는 유의적으로 증가하였다. TCDD와 홍삼추출물의 단독 또는 병행 투여군에서의 뇌의 무게는 유의적인 변화를 보이지 않았다. 실험동물 뇨에서의 specific gravity는 대조군에서 주령에 상관없이 대체적으로 1.030 이상의 수준을 유지하였으나 홍삼추출물을 단독 투여한 흰쥐에서는 투여 후 14일부터 specific gravity가 1.02 수준으로 낮아지는 경향이 나타났다. TCDD 단독 투여군에서는 투여 초기에 specific gravity가 1.02 수준으로 감소하는 경향이 있었으나 홍삼추출물을 병행투여했을때 1.02 수준으로 감소하는 경향이 14일 이후에 나타났다. 실험동물 뇨에서의 Total protein 함량은 대조군에서 전체 실험기간 동안에 $100\;{\mu}g/dL$ 수준을 유지하였으나, TCDD 단독 투여군과 TCDD와 홍삼추출물의 병행 투여군에서는 $300\;{\mu}g/dL$ 이상의 함량을 나타내는 개체수가 증가하는 현상을 보였다. 한편, 홍삼추출물 단독 투여군에서는 대조군에서와 비슷한 Total protein 함량의 수준을 나타내었다. 뇨에서 ketone body의 함량은 대조군에서 주령의 증가에 따라 높아지는 경향을 나타내었으나 실험군 간의 차이는 나타나지 않았다. Glucose, ketone, bilirubin, Occult blood, nitrite 및 urobilinogen의 함량은 모든 실험군에서 거의 유사하게 나타났으며, pH 값은 주령의 증가에 따라 높아지는 경향이 특징적이었으나 실험군간의 차이는 나타나지 않았다. 혈액화학적 검사결과 TCDD의 단독투여에 의한 AST는 대조군에 비하여 전 실험기간에 걸쳐서 전반적으로 높게 나타났으며, 특히 32일 실험군에서 가장 높은 AST 값을 나타내었다. 홍삼추출물의 단독 투여에 의한 AST는 TCDD의 단독 투여군과는 대조적으로 오히려 노출기간이 경과할수록 감소하였다. 그리고 TCDD의 투여에 의해 증가된 AST는 홍삼추출물을 병행투여 한 지 16일부터 정상 수준으로 회복되었다. TCDD를 단독 투여한 흰쥐 혈청 ALT의 활성은 16일 까지는 대조군의 ALT 활성과 비슷한 수준이었으나 32일 째에는 대조군에 비하여 상당히 증가하였다. 이에 비하여 TCDD와 홍삼추출물을 병행 투여한 실험군에서는 16일군과 32일군에서 ALT의 활성이 급격히 감소하여 대조군의 ALT 활성보다 낮게 나타났다. 홍삼을 단독 투여한 실험군에서의 ALT 활성은 전 실험기간동안에 ALT 활성에 영향을 주지 않았다.

• 대한한방내과학회지
• /
• 제29권2호
• /
• pp.500-511
• /
• 2008

The aim of this study was to investigate the inhibitory effect of Saengangeonbitang-gasamchilgn(SGGBTGSCG) on collagen production in rat hepatic stellate cells(HSC) and on the TAA-induced chronic liver injury model in rats. Methods : 1) HSCs were treated with SGGBTGSCG extract powder(50% EtOH SGGBTGSCG, dw SGGBTGSCG). After the treatment, MTT assay, BrdU assay and procollagen assay were done. In addition, gene expressions of collagen type $1{\alpha}2$, ASMA, TIMP1, and TIMP2, all of which are known to be associated with liver fibrosis, were analyzed by RT-PCR. 2) Liver fibrosis was developed in rats by injection of TAA 3 times a week for 5 weeks. After the SGGBTGSCG-treatment, body weight, liver & spleen weight, liver function test, the complete blood cell count and the change of portal pressure were studied. Results : In MTT assay, SGGBTGSCG significantly decreased the viability of HSCs in a dose-dependent manner. In BrdU assay, SGGBTGSCG significantly inhibited the HSC proliferation in a dose-dependant manner. In procollagen assay, SGGBTGSCG decreased procollagen production by HSC. In the change of rats' liver and spleen weight, TAA+SGGBTGSCG groups showed little difference compared with TAA-only group. In the liver function test, SGGBTGSCG decreased the serum level of ALT, AST, and Alp elevated by TAA. In the complete blood cell count, SGGBTGSCG significantly decreased WBC elevated by TAA and increased RBC and Hct lowered by TAA. In the change of portal pressure, SGGBTGSCG decreased portal pressure elevated by TAA. Conclusions : These results suggest that SGGBTGSCG is beneficial in the treatment of cirrhotic patients as well as for patients with chronic hepatitis.

• 한국자원식물학회지
• /
• 제26권3호
• /
• pp.337-346
• /
• 2013

This study is a basic study on the development of functional substances involved in obesity prevention, lipid metabolism, and immune regulation. Male Sprague-Dawley rats were fed a high-fat diet for 10 weeks. Allium monanthum extracts (AME) were administered orally to obesity-induced rats, and their lipid-lowering, antioxidative and various types of biological effects related to the immune system were examined. Blood free fatty acid and triglyceride concentrations decreased as the dose of AME increased. Total cholesterol and LDL cholesterol concentrations in the blood decreased as the dose of AME increased. The total cholesterol concentrations in the liver of the AME-treated groups were lower than the control group. The thiobarbituric acid reactive concentrations were lower in the plasma and liver of all AME-treated groups than the control group. Plasma AST and ALT activities did not show any significant differences among the treatment groups. IL-$1{\beta}$ and IL-6 concentrations in the liver tended to decrease as the dose of AME increased. TNF-${\alpha}$ and IL-10 concentrations did now show any significant differences compared to the control group. Lower expression levels of TNF-${\alpha}$, Apo-B and Apo-E genes were found in the AME-treated groups. Taken together, these results indicate that AME may show positive effects in lipid lowering, antioxidation and anti-inflammation.

• 대한한방내과학회지
• /
• 제32권4호
• /
• pp.550-564
• /
• 2011

Objectives : Oxidative stress seems to play a major role in mechanisms by which ethanol causes liver injury. Previous studies have shown that treatment with Yinjinchunggan-tang (Yinchenqinggan-tang, YJCGT) has protective effects on alcoholic liver disease. The aim of this study was to investigate the protective effects of YJCGT on alcohol-induced oxidative stress. Materials and Methods : In vitro, we evaluated the inhibitory activities of YJCHT on DPPH(1,1-diphenyl-2-picryl-hydrazyl), xanthine oxidase, trypsin, and hyaluronidase. In a cell culture model, we measured cell viability and proliferation, and the activities of superoxide dismutase (SOD), and catalase (CAT) after YJCGT treatment in C34 and E47 cell lines, and HepG2 cells transfected with/ without cytochrome P450IIE1 (CYP2E1) gene. In vivo, we estimated serum level of hepatic biochemical markers, and alcohol concentration in the blood. Results : YJCGT showed significant free radical scavenging activity against DPPH and xanthine oxidase and decreased hyaluronidase activity effectively in vitro. YJCGT also increased cell viability, and proliferation in C34 and in E47 cell lines, and increased activities of superoxide dismutase, and catalase in C34 and in E47 cell lines. YJCGT reduced serum AST, LDH, and total cholesterol level in some of the results, and reduced blood alcohol concentration in vivo, as well. Conclusions : This study suggests that YJCGT has protective effects on oxidative stress by inhibiting alcohol-induced suppression of antioxidant enzyme activities.

• Asian-Australasian Journal of Animal Sciences
• /
• 제27권1호
• /
• pp.123-130
• /
• 2014

The A-type lamin deficient mouse line ($Lmna^{-/-}$) has become one of the most frequently used models for providing insights into many different aspects of A-type lamin function. To elucidate the function of Lmna in the growth and metabolism of mice, tissue growth and blood biochemistry were monitored in Lmna-deficient mice, heterozygous ($Lmna^{+/-}$) and wide-type ($Lmna^{+/+}$) backcrossed to C57BL/6 background. At 4 weeks after birth, the weight of various organs of the $Lmna^{-/-}$, $Lmna^{+/-}$ and $Lmna^{+/+}$ mice was measured. A panel of biochemical analyses consisting of 15 serological tests was examined. The results showed that Lmna deficient mice had significantly decreased body weight and increased the ratio of organ to body weight in most of tissues. Compared with $Lmna^{+/+}$ and $Lmna^{+/-}$ mice, $Lmna^{-/-}$ mice exhibited lower levels of ALP (alkaline phosphatase), Chol (cholesterol), CR (creatinine), GLU (glucose), HDL (high-density lipoprotein cholesterol) and higher levels of ALT (alanine aminotransferase) (p<0.05). $Lmna^{-/-}$ mice displayed higher AST (aspartate aminotransferase) values and lower LDL (lowdensity lipoprotein cholesterol), CK-MB (creatine kinase-MB) levels than $Lmna^{+/+}$ mice (p<0.05). There were no significant differences among the three groups of mice with respect to BUN (blood urea nitrogen), CK (creatine kinase), Cyc C (cystatin C), TP (total protein), TG (triacylglycerols) and UA (uric acid) levels (p>0.05). These changes of serological parameters may provide an experimental basis for the elucidation of Lmna gene functions.

• 대한한의학회지
• /
• 제29권1호
• /
• pp.85-94
• /
• 2008

Objectives : The purpose of this study was to investigate effects of extract from mixed culture with Tricholoma matsutake mycelium and Cordyceps militaris mycelium in oriental medicine and cereal midium (OCM) considered effective for the treatment of diabetes. Methods : We examined antioxidant activity and $\alpha$-glucosidase inhibit activity of OCM and orally administered OCM extracts to Streptozotocin-induced diabetic ratsat the dose of 100mg/kg, 200mg/kg and 300mg/kg body weight. Results : Total polyphenol content of extracts of OCM was 26.41 mg/g, DPPH radical scavenging activity was 32.24% and SOD-like activity was 31.43%. $\alpha$-glucosidase inhibit activity showed 85.3% of acarbose. Blood glucose levels of the OCM extracts-treated groups were lower than those of the diabetic control group (DC), total cholesterol and triglyceride contents were similar to the acarbose-treated group (PC) and ALT, AST were lower than the DC and PC groups. The 300 mg/kg body weight administered group (UM-300) were superior to other OCM-treated groups (UM-100, UM-200). Conclusions : These results showed extract from mixed culture with Tricholoma matsutake mycelium and Cordyceps militaris mycelium in oriental medicine and cereal midium has potentiality to beused in pharmaceutical products and medicinal food for preventive and treatment diabetes mellitus.

• 동의생리병리학회지
• /
• 제16권4호
• /
• pp.734-744
• /
• 2002

The purpose of this study was to evaluate the protective effect of Kamicheonggan-tang(KCGT) on pre-hepatocarcinogenesis induced by N-nitrosomorpholine. The studied using blood chemistry, lipidperoxidation, antioxidant, immunohistochemistry and morphological change. The results were obtained as follows. In the pre-hepatocarcinogenesis induced by NMP, serum AST, ALT, ALP and total bilirubin were not changed in NMP and NK treated group after 1 st week, but desreased in NK treated group after 4th week as compared with NMP treated 4th week group. The content of GSH was similary to in NK treated groups as compares with data of normal group. The content of MDA was increased in NK treated group after 1st and 4th week, and more increased in the NMP treated group than those of their NK treated group. The immunohistochemically, stain of GST-p, positive lesions of KCGT were significantly decreased than those of NMP treated group. The histopathologically, fat changes, nucleotic changes, oval cell and inflammatory cells in periportal were observed in NMP treated fater 4th week, but those were significantly decreased from 4th week in the NK treated group. And the enlarged nucleus was not changed in KCGT treated group, but increased in NMP treated group after 1st and 4th week. The ultrastructurally, nucleotic changes, glycogen degeneration, lipid droplet and rER fragmentation were observed in NMP treated group after 4th week, but those changes were significantly decreased from 4th week in the NK treated group. These results suggested that KCGT extracts has protective effect on prehepatocarcinogenesis by NMP, might be usefully applied for clinical treatment of hapatic disease and also it was necessary to do more studies about its mechanisms.